/C O R R E C T I O N -- Shire PLC/
Shire PLC (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) the global specialtybiopharmaceutical company, will announce third quarter 2007 earnings onThursday 1 November 2007.
Live conference call for investors:
Matthew Emmens, Chief Executive Officer and Angus Russell, ChiefFinancial Officer will host the live conference call for investors at 14:30GMT/10:30 ET.
Please RSVP firstname.lastname@example.org (T: +44(0)1256-894-160) for this conferencecall.
A replay of the presentation will be available for two weeks by phone andby webcast for one year. Details are as follows:
Shire's strategic goal is to become the leading specialtybiopharmaceutical company that focuses on meeting the needs of the specialistphysician. Shire focuses its business on attention deficit and hyperactivitydisorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) andrenal diseases. The structure is sufficiently flexible to allow Shire totarget new therapeutic areas to the extent opportunities arise throughacquisitions. Shire's in-licensing, merger and acquisition efforts arefocused on products in niche markets with strong intellectual propertyprotection either in the US or Europe. Shire believes that a carefullyselected portfolio of products with strategically aligned and relativelysmall-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website:http://www.shire.com.Results press release will be issued at: 12:00 GMT / 08:00 ET Investor meeting and conference call time: 14:30 GMT / 10:30 ET
SOURCE Shire PLC
You May Also Like